Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer

OBJECTIVES: We previously reported the feasibility of neoadjuvant capecitabine and oxaliplatin plus bevacizumab as a treatment for locally advanced rectal cancer (UMIN000003219). The aim of this study is to investigate the prognostic relevance of neoadjuvant chemotherapy followed by total mesorectal...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Anus Rectum Colon
Главные авторы: Nishimura, Junichi, Hasegawa, Junichi, Noura, Shingo, Ikeda, Kimimasa, Yasui, Masayoshi, Komori, Takamichi, Tsujie, Masaki, Yasumasa, Keigo, Shingai, Tatsushi, Uemura, Mamoru, Hata, Taishi, Matsuda, Chu, Mizushima, Tsunekazu, Ikeda, Masataka, Doki, Yuichiro, Mori, Masaki
Формат: Artigo
Язык:Inglês
Опубликовано: The Japan Society of Coloproctology 2020
Предметы:
Original Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7390618/
https://ncbi.nlm.nih.gov/pubmed/32743112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23922/jarc.2019-042
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы